FDA to Decide on Neuralink Mass-Market Brain Implant Trial
A Pivotal Moment for NeurotechnologyThe United States Food and Drug Administration (FDA) is preparing to deliver a landmark decision regarding Neuralink’s application to launch its first mass-market clinical trial. The…[...]
Read More